This inventor holds 3 USPTO granted patents. Top assignee: University Health Network. Active years: 2013-2018.
Company Filing History:
Years Active: 2013-2018
Title: Sean Devine: Innovator in Thymidylate Kinase Research
Introduction
Sean Devine is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapies for various diseases. With a total of 3 patents to his name, Devine's work focuses on enhancing treatment options for conditions such as graft versus host disease and cancer.
Latest Patents
Sean Devine's latest patents include groundbreaking work on thymidylate kinase fusions. One of his applications relates to a composition that comprises a stably integrating delivery vector, a modified mammalian thymidylate kinase (tmpk) that increases the phosphorylation of a prodrug compared to the phosphorylation by wild-type human tmpk. This invention also includes a detection cassette fused to the tmpk, which is crucial for the application in treatment methods for diseases like graft versus host disease and cancer.
Another patent by Devine similarly focuses on thymidylate kinase fusions. This application outlines a composition that includes a stably integrating delivery vector and a modified mammalian tmpk that enhances the phosphorylation of a prodrug. The detection cassette fused to the tmpk is also a key component of this invention, emphasizing its potential in therapeutic applications.
Career Highlights
Sean Devine is affiliated with the University Health Network, where he conducts his research and development work. His innovative approach to biomedical research has positioned him as a leading figure in his field.
Collaborations
One of his notable collaborators is Jeffrey A. Medin, with whom he has worked on various projects related to thymidylate kinase research.
Conclusion
Sean Devine's contributions to the field of biomedical research through his patents on thymidylate kinase fusions highlight his commitment to advancing treatment options for serious diseases. His work continues to pave the way for innovative therapies that can significantly impact patient care.